{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:07:34Z","timestamp":1792130854388,"version":"4.4.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T00:00:00Z","timestamp":1649462400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T00:00:00Z","timestamp":1649462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1R01 HL142049-03"],"award-info":[{"award-number":["1R01 HL142049-03"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["5R01HL114587-06"],"award-info":[{"award-number":["5R01HL114587-06"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Most phenotyping paradigms in sarcoidosis are based on expert opinion; however, no paradigm has been widely adopted because of the subjectivity in classification. We hypothesized that cluster analysis could be performed on common clinical variables to define more objective sarcoidosis phenotypes.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We performed a retrospective cohort study of 554 sarcoidosis cases to identify distinct phenotypes of sarcoidosis based on 29 clinical features. Model-based clustering was performed using the VarSelLCM R package and the Integrated Completed Likelihood (ICL) criteria were used to estimate number of clusters. To identify features associated with cluster membership, features were ranked based on variable importance scores from the VarSelLCM model, and additional univariate tests (Fisher\u2019s exact test and one-way ANOVA) were performed using q-values correcting for multiple testing. The Wasfi severity score was also compared between clusters.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Cluster analysis resulted in 6 sarcoidosis phenotypes. Salient characteristics for each cluster are as follows: Phenotype (1) supranormal lung function and majority Scadding stage 2\/3; phenotype (2) supranormal lung function and majority Scadding stage 0\/1; phenotype (3) normal lung function and split Scadding stages between 0\/1 and 2\/3; phenotype (4) obstructive lung function and majority Scadding stage 2\/3; phenotype (5) restrictive lung function and majority Scadding stage 2\/3; phenotype (6) mixed obstructive and restrictive lung function and mostly Scadding stage 4. Although there were differences in the percentages, all Scadding stages were encompassed by all of the phenotypes, except for phenotype 1, in which none were Scadding stage 4. Clusters 4, 5, 6 were significantly more likely to have ever been on immunosuppressive treatment and had higher Wasfi disease severity scores.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Cluster analysis produced 6 sarcoidosis phenotypes that demonstrated less severe and severe phenotypes. Phenotypes 1, 2, 3 have less lung function abnormalities, a lower percentage on immunosuppressive treatment and lower Wasfi severity scores. Phenotypes 4, 5, 6 were characterized by lung function abnormalities, more parenchymal abnormalities, an increased percentage on immunosuppressive treatment and higher Wasfi severity scores. These data support using cluster analysis as an objective and clinically useful way to phenotype sarcoidosis subjects and to empower clinicians to identify those with more severe disease versus those who have less severe disease, independent of Scadding stage.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12931-022-01993-z","type":"journal-article","created":{"date-parts":[[2022,4,9]],"date-time":"2022-04-09T05:02:29Z","timestamp":1649480549000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Clinical phenotyping in sarcoidosis using cluster analysis"],"prefix":"10.1186","volume":"23","author":[{"given":"Nancy W.","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaron","family":"Arbet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret M.","family":"Mroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Yi","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clara I.","family":"Restrepo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annyce S.","family":"Mayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Briana Q.","family":"Barkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Schrock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nabeel","family":"Hamzeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasha E.","family":"Fingerlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nichole E.","family":"Carlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6872-1769","authenticated-orcid":false,"given":"Lisa A.","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,9]]},"reference":[{"key":"1993_CR1","doi-asserted-by":"publisher","unstructured":"Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ER. Am J Respir Crit Care Med. 1999;160(2):736-755. https:\/\/doi.org\/10.1164\/ajrccm.160.2.ats4-99.","DOI":"10.1164\/ajrccm.160.2.ats4-99"},{"issue":"8","key":"1993_CR2","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1164\/rccm.202002-0251ST","volume":"201","author":"ED Crouser","year":"2020","unstructured":"Crouser ED, Maier LA, Wilson KC, Bonham CA, Morgenthau AS, Patterson KC, et al. Diagnosis and detection of sarcoidosis. An official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2020;201(8):e26\u201351. https:\/\/doi.org\/10.1164\/rccm.202002-0251ST.","journal-title":"Am J Respir Crit Care Med"},{"issue":"5","key":"1993_CR3","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1097\/MCP.0000000000000077","volume":"20","author":"CAC Pereira","year":"2014","unstructured":"Pereira CAC, Dornfeld MC, Baughman R, Judson MA. Clinical phenotypes in sarcoidosis. Curr Opin Pulm Med. 2014;20(5):496\u2013502. https:\/\/doi.org\/10.1097\/MCP.0000000000000077.","journal-title":"Curr Opin Pulm Med"},{"issue":"1","key":"1993_CR4","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1111\/j.1749-6632.1986.tb18537.x","volume":"465","author":"HL Israel","year":"1986","unstructured":"Israel HL, Karlin P, Menduke H, DeLisser OG. Factors affecting outcome of sarcoidosis. Influence of race, extrathoracic involvement, and initial radiologic lung lesions. Ann N Y Acad Sci. 1986;465(1):609\u201318. https:\/\/doi.org\/10.1111\/j.1749-6632.1986.tb18537.x.","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"1993_CR5","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1183\/09031936.93.06030349","volume":"6","author":"K Viskum","year":"1993","unstructured":"Viskum K, Vestbo J. Vital prognosis in intrathoracic sarcoidosis with special reference to pulmonary function and radiological stage. Eur Respir J. 1993;6(3):349\u201353.","journal-title":"Eur Respir J"},{"issue":"4","key":"1993_CR6","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1378\/chest.14-1099","volume":"147","author":"YC Cozier","year":"2015","unstructured":"Cozier YC, Coogan PF, Govender P, Berman JS, Palmer JR, Rosenberg L. Obesity and weight gain in relation to incidence of sarcoidosis in US black women: data from the Black Women\u2019s Health Study. Chest. 2015;147(4):1086\u201393. https:\/\/doi.org\/10.1378\/chest.14-1099.","journal-title":"Chest"},{"issue":"3","key":"1993_CR7","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1378\/chest.111.3.623","volume":"111","author":"JE Gottlieb","year":"1997","unstructured":"Gottlieb JE, Israel HL, Steiner RM, Triolo J, Patrick H. Outcome in sarcoidosis: The relationship of relapse to corticosteroid therapy. Chest. 1997;111(3):623\u201331. https:\/\/doi.org\/10.1378\/chest.111.3.623.","journal-title":"Chest"},{"issue":"5","key":"1993_CR8","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1378\/chest.129.5.1234","volume":"129","author":"YS Wasfi","year":"2006","unstructured":"Wasfi YS, Rose CS, Murphy JR, Silveira LJ, Grutters JC, Inoue Y, et al. A new tool to assess sarcoidosis severity. Chest. 2006;129(5):1234\u201345. https:\/\/doi.org\/10.1378\/chest.129.5.1234.","journal-title":"Chest"},{"issue":"1","key":"1993_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1465-9921-14-121","volume":"14","author":"R Su","year":"2013","unstructured":"Su R, Nguyen MLT, Agarwal MR, Kirby C, Nguyen CP, Ramstein J, et al. Interferon-inducible chemokines reflect severity and progression in sarcoidosis. Respir Res. 2013;14(1):1. https:\/\/doi.org\/10.1186\/1465-9921-14-121.","journal-title":"Respir Res"},{"issue":"10","key":"1993_CR10","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1007\/s10067-018-4183-2","volume":"37","author":"M Ando","year":"2018","unstructured":"Ando M, Goto A, Takeno Y, Yamasue M, Komiya K, Umeki K, et al. Significant elevation of the levels of B-cell activating factor (BAFF) in patients with sarcoidosis. Clin Rheumatol. 2018;37(10):2833\u20138. https:\/\/doi.org\/10.1007\/s10067-018-4183-2.","journal-title":"Clin Rheumatol"},{"issue":"3","key":"1993_CR11","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1164\/rccm.200711-1754OC","volume":"178","author":"P Haldar","year":"2008","unstructured":"Haldar P, Pavord ID, Shaw DE, Berry MA, Thomas M, Brightling CE, et al. Cluster analysis and clinical asthma phenotypes. Am J Respir Crit Care Med. 2008;178(3):218\u201324. https:\/\/doi.org\/10.1164\/rccm.200711-1754OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"4","key":"1993_CR12","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1164\/rccm.200906-0896OC","volume":"181","author":"WC Moore","year":"2010","unstructured":"Moore WC, Meyers DA, Wenzel SE, Teague WG, Li H, Li X, et al. Identification of asthma phenotypes using cluster analysis in the severe asthma research program. Am J Respir Crit Care Med. 2010;181(4):315\u201323. https:\/\/doi.org\/10.1164\/rccm.200906-0896OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"1993_CR13","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1183\/13993003.00991-2017","volume":"51","author":"JC Schupp","year":"2018","unstructured":"Schupp JC, Freitag-Wolf S, Bargagli E, Mihailovi\u0107-Vu\u010dini\u0107 V, Rottoli P, Grubanovic A, et al. Phenotypes of organ involvement in sarcoidosis. Eur Respir J. 2018;51(1):1\u201311. https:\/\/doi.org\/10.1183\/13993003.00991-2017.","journal-title":"Eur Respir J"},{"issue":"April","key":"1993_CR14","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ejim.2020.04.024","volume":"77","author":"M Rubio-Rivas","year":"2020","unstructured":"Rubio-Rivas M, Corbella X. Clinical phenotypes and prediction of chronicity in sarcoidosis using cluster analysis in a prospective cohort of 694 patients. Eur J Intern Med. 2020;77(April):59\u201365. https:\/\/doi.org\/10.1016\/j.ejim.2020.04.024.","journal-title":"Eur J Intern Med"},{"key":"1993_CR15","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01160-2020","author":"R Lhote","year":"2020","unstructured":"Lhote R, Annesi-Maesano I, Nunes H, Launay D, Borie R, Sacr\u00e9 K, et al. Clinical phenotypes of extrapulmonary sarcoidosis: an analysis of a French, multiethnic, multicenter cohort. Eur Respir J. 2020. https:\/\/doi.org\/10.1183\/13993003.01160-2020.","journal-title":"Eur Respir J"},{"key":"1993_CR16","doi-asserted-by":"crossref","unstructured":"Lin N, Arbet J, Liao S, Mroz M, Restrepo C, Barkes B, Li L, Fingerlin T, Carlson N, Maier L. Comparing cluster analysis to expert opinion in phenotyping sarcoidosis. American Thoracic Society Conference. Published online 2021.","DOI":"10.1164\/ajrccm-conference.2021.203.1_MeetingAbstracts.A3140"},{"issue":"11","key":"1993_CR17","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.1164\/rccm.201710-1981ST","volume":"196","author":"BH Culver","year":"2017","unstructured":"Culver BH, Graham BL, Coates AL, Wanger J, Berry CE, Clarke PK, et al. Recommendations for a standardized pulmonary function report. An official American Thoracic Society technical statement. Am J Respir Crit Care Med. 2017;196(11):1463\u201372. https:\/\/doi.org\/10.1164\/rccm.201710-1981ST.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"1993_CR18","first-page":"19","volume":"31","author":"MA Judson","year":"2014","unstructured":"Judson MA, Costabel U, Drent M, Wells A, Maier L, Koth L, et al. The WASOG sarcoidosis organ assessment instrument: an update of a previous clinical tool. Sarcoidosis Vasc Diffus Lung Dis. 2014;31(1):19\u201327.","journal-title":"Sarcoidosis Vasc Diffus Lung Dis"},{"key":"1993_CR19","unstructured":"R Core Team. R: A language and environment for statistical computing. Published online 2020."},{"issue":"7","key":"1993_CR20","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1093\/bioinformatics\/bty786","volume":"35","author":"M Marbac","year":"2019","unstructured":"Marbac M, Sedki M. VarSelLCM: an R\/C++ package for variable selection in model-based clustering of mixed-data with missing values. Bioinformatics. 2019;35(7):1255\u20137. https:\/\/doi.org\/10.1093\/bioinformatics\/bty786.","journal-title":"Bioinformatics"},{"key":"1993_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1214\/18-SS119","volume":"12","author":"M Fop","year":"2018","unstructured":"Fop M, Murphy TB. Variable selection methods for model-based clustering. Stat Surv. 2018;12:18\u201365. https:\/\/doi.org\/10.1214\/18-SS119.","journal-title":"Stat Surv"},{"issue":"7","key":"1993_CR22","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1109\/34.865189","volume":"22","author":"C Biernacki","year":"2000","unstructured":"Biernacki C, Celeux G, Govaert G. Assessing a mixture model for clustering with the integrated completed likelihood. IEEE Trans Pattern Anal Mach Intell. 2000;22(7):719\u201325. https:\/\/doi.org\/10.1109\/34.865189.","journal-title":"IEEE Trans Pattern Anal Mach Intell"},{"issue":"1","key":"1993_CR23","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B. 1995;57(1):289\u2013300. https:\/\/doi.org\/10.1111\/j.2517-6161.1995.tb02031.x.","journal-title":"J R Stat Soc Ser B"},{"issue":"4","key":"1993_CR24","first-page":"275","volume":"31","author":"RP Baughman","year":"2014","unstructured":"Baughman RP, Lower EE. Features of sarcoidosis associated with chronic disease. Sarcoidosis Vasc Diffus Lung Dis. 2014;31(4):275\u201381.","journal-title":"Sarcoidosis Vasc Diffus Lung Dis"},{"issue":"5","key":"1993_CR25","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1159\/000196564","volume":"63","author":"J Ma\u00f1\u00e1","year":"1996","unstructured":"Ma\u00f1\u00e1 J, Salazar A, Pujol R, Manresa F. Are the pulmonary function tests and the markers of activity helpful to establish the prognosis of sarcoidosis. Respiration. 1996;63(5):298\u2013303. https:\/\/doi.org\/10.1159\/000196564.","journal-title":"Respiration"},{"issue":"2","key":"1993_CR26","first-page":"154","volume":"14","author":"RP Baughman","year":"1997","unstructured":"Baughman RP, Winget DB, Bowen EH, Lower EE. Predicting respiratory failure in sarcoidosis patients. Sarcoidosis, Vasc Diffus lung Dis Off J WASOG. 1997;14(2):154\u20138.","journal-title":"Sarcoidosis, Vasc Diffus lung Dis Off J WASOG."},{"issue":"5","key":"1993_CR27","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1093\/qjmed\/hcl038","volume":"99","author":"RP Baughman","year":"2006","unstructured":"Baughman RP, Judson MA, Teirstein A, Yeager H, Rossman M, Knatterud GL, et al. Presenting characteristics as predictors of duration of treatment in sarcoidosis. QJM Mon J Assoc Physicians. 2006;99(5):307\u201315. https:\/\/doi.org\/10.1093\/qjmed\/hcl038.","journal-title":"QJM Mon J Assoc Physicians"},{"issue":"3","key":"1993_CR28","first-page":"204","volume":"20","author":"MA Judson","year":"2003","unstructured":"Judson MA, Baughman RP, Thompson BW, Teirstein AS, Terrin ML, Rossman MD, et al. Two year prognosis of sarcoidosis: the ACCESS experience. Sarcoidosis Vasc Diffus Lung Dis. 2003;20(3):204\u201311.","journal-title":"Sarcoidosis Vasc Diffus Lung Dis"},{"issue":"2","key":"1993_CR29","doi-asserted-by":"publisher","first-page":"123","DOI":"10.36141\/svdld.v35i2.6356","volume":"35","author":"P Ungprasert","year":"2018","unstructured":"Ungprasert P, Crowson CS, Carmona EM, Matteson EL. Outcome of pulmonary sarcoidosis: a population-based study 1976\u20132013. Sarcoidosis Vasc Diffus Lung Dis. 2018;35(2):123\u20138. https:\/\/doi.org\/10.36141\/svdld.v35i2.6356.","journal-title":"Sarcoidosis Vasc Diffus Lung Dis"},{"issue":"11","key":"1993_CR30","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1164\/rccm.201010-1679OC","volume":"183","author":"JJ Swigris","year":"2011","unstructured":"Swigris JJ, Olson AL, Huie TJ, Fernandez-Perez ER, Solomon J, Sprunger D, et al. Sarcoidosis-related mortality in the United States from 1988 to 2007. Am J Respir Crit Care Med. 2011;183(11):1524\u201330. https:\/\/doi.org\/10.1164\/rccm.201010-1679OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"1993_CR31","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1378\/chest.14-1120","volume":"147","author":"M Mirsaeidi","year":"2015","unstructured":"Mirsaeidi M, Machado RF, Schraufnagel D, Sweiss NJ, Baughman RP. Racial difference in sarcoidosis mortality in the United States. Chest. 2015;147(2):438\u201349. https:\/\/doi.org\/10.1378\/chest.14-1120.","journal-title":"Chest"},{"key":"1993_CR32","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.164.10.2104046","author":"RP Baughman","year":"2001","unstructured":"Baughman RP, Teirstein AS, Judson MA, Rossman MD, Yeager H, Bresnitz EA, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med. 2001. https:\/\/doi.org\/10.1164\/ajrccm.164.10.2104046.","journal-title":"Am J Respir Crit Care Med"},{"key":"1993_CR33","doi-asserted-by":"publisher","first-page":"S421","DOI":"10.1513\/AnnalsATS.201707-564OT","volume":"14","author":"AK Gerke","year":"2017","unstructured":"Gerke AK, Judson MA, Cozier YC, Culver DA, Koth LL. Disease burden and variability in sarcoidosis. Ann Am Thorac Soc. 2017;14:S421\u20138. https:\/\/doi.org\/10.1513\/AnnalsATS.201707-564OT.","journal-title":"Ann Am Thorac Soc"},{"issue":"1","key":"1993_CR34","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/0002-9343(60)90009-7","volume":"29","author":"M Sones","year":"1960","unstructured":"Sones M, Israel HL. Course and prognosis of sarcoidosis. Am J Med. 1960;29(1):84\u201393. https:\/\/doi.org\/10.1016\/0002-9343(60)90009-7.","journal-title":"Am J Med"},{"issue":"3","key":"1993_CR35","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.rmed.2016.10.003","volume":"120","author":"P Ungprasert","year":"2016","unstructured":"Ungprasert P, Crowson CS, Matteson EL. Smoking, obesity and risk of sarcoidosis: a population-based nested case-control study. Respir Med. 2016;120(3):87\u201390. https:\/\/doi.org\/10.1016\/j.rmed.2016.10.003.","journal-title":"Respir Med"},{"issue":"12","key":"1993_CR36","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1164\/rccm.200402-249OC","volume":"170","author":"LS Newman","year":"2004","unstructured":"Newman LS, Rose CS, Bresnitz EA, Rossman MD, Barnard J, Frederick M, et al. A case control etiologic study of sarcoidosis: environmental and occupational risk factors. Am J Respir Crit Care Med. 2004;170(12):1324\u201330. https:\/\/doi.org\/10.1164\/rccm.200402-249OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"7","key":"1993_CR37","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1136\/thx.43.7.516","volume":"43","author":"D Valeyre","year":"1988","unstructured":"Valeyre D, Soler P, Clerici C, Pr\u00e9 J, Battesti JP, Georges R, et al. Smoking and pulmonary sarcoidosis: Effect of cigarette smoking on prevalence, clinical manifestations, alveolitis, and evolution of the disease. Thorax. 1988;43(7):516\u201324. https:\/\/doi.org\/10.1136\/thx.43.7.516.","journal-title":"Thorax"},{"issue":"1","key":"1993_CR38","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/j.1749-6632.1986.tb18539.x","volume":"465","author":"RA Harf","year":"1986","unstructured":"Harf RA, Ethevenaux C, Gleize J, Perrin-Fayolle M, Guerin JC, Ollagnier C. Reduced prevalence of smokers in sarcoidosis. Results of a case-control study. Ann N Y Acad Sci. 1986;465(1):625\u201331. https:\/\/doi.org\/10.1111\/j.1749-6632.1986.tb18539.x.","journal-title":"Ann N Y Acad Sci"},{"issue":"10","key":"1993_CR39","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1002\/ajim.20736","volume":"52","author":"MM Mroz","year":"2009","unstructured":"Mroz MM, Maier LA, Strand M, Silviera L, Newman LS. Beryllium lymphocyte proliferation test surveillance identifies clinically significant beryllium disease. Am J Ind Med. 2009;52(10):762\u201373. https:\/\/doi.org\/10.1002\/ajim.20736.","journal-title":"Am J Ind Med"},{"issue":"8","key":"1993_CR40","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1164\/rccm.200210-1154oc","volume":"169","author":"MR Blanchet","year":"2004","unstructured":"Blanchet MR, Isra\u00ebl-Assayag E, Cormier Y. Inhibitory effect of nicotine on experimental hypersensitivity pneumonitis in vivo and in vitro. Am J Respir Crit Care Med. 2004;169(8):903\u20139. https:\/\/doi.org\/10.1164\/rccm.200210-1154oc.","journal-title":"Am J Respir Crit Care Med"},{"issue":"11","key":"1993_CR41","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1136\/thx.2006.062836","volume":"61","author":"J Gribbin","year":"2006","unstructured":"Gribbin J, Hubbard RB, Le Jeune I, Smith CJP, West J, Tata LJ. Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax. 2006;61(11):980\u20135. https:\/\/doi.org\/10.1136\/thx.2006.062836.","journal-title":"Thorax"},{"issue":"191","key":"1993_CR42","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2021.106688","volume":"2022","author":"A Lundkvist","year":"2021","unstructured":"Lundkvist A, Kullberg S, Arkema EV, Cedelund K, Eklund A, Grunewald J, et al. Differences in disease presentation between men and women with sarcoidosis: a cohort study. Respir Med. 2021;2022(191): 106688. https:\/\/doi.org\/10.1016\/j.rmed.2021.106688.","journal-title":"Respir Med"},{"issue":"2","key":"1993_CR43","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1080\/17476348.2020.1684902","volume":"14","author":"SA Papiris","year":"2020","unstructured":"Papiris SA, Georgakopoulos A, Papaioannou AI, Pianou N, Kallergi M, Kelekis NL, et al. Emerging phenotypes of sarcoidosis based on 18F-FDG PET\/CT: a hierarchical cluster analysis. Expert Rev Respir Med. 2020;14(2):229\u201338. https:\/\/doi.org\/10.1080\/17476348.2020.1684902.","journal-title":"Expert Rev Respir Med"},{"issue":"6","key":"1993_CR44","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1183\/09031936.00187410","volume":"38","author":"A Nardi","year":"2011","unstructured":"Nardi A, Brillet PY, Letoumelin P, Girard F, Brauner M, Uzunhan Y, et al. Stage IV sarcoidosis: comparison of survival with the general population and causes of death. Eur Respir J. 2011;38(6):1368\u201373. https:\/\/doi.org\/10.1183\/09031936.00187410.","journal-title":"Eur Respir J"},{"issue":"1","key":"1993_CR45","first-page":"34","volume":"28","author":"SCS Rodrigues","year":"2011","unstructured":"Rodrigues SCS, Rocha NAS, Lima MS, Arakaki JSO, Coletta ENA, Ferreira RG, et al. Factor analysis of sarcoidosis phenotypes at two referral centers in Brazil. Sarcoidosis Vasc Diffus Lung Dis. 2011;28(1):34\u201343.","journal-title":"Sarcoidosis Vasc Diffus Lung Dis"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-022-01993-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-022-01993-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-022-01993-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T01:29:26Z","timestamp":1675214966000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-022-01993-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,9]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1993"],"URL":"https:\/\/doi.org\/10.1186\/s12931-022-01993-z","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-820722\/v1","asserted-by":"object"}]},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,9]]},"assertion":[{"value":"20 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All subjects provided written informed consent to participate in this study. The study was approved by the NJH Institutional Review Board (HS 2458).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"88"}}